APUS - Apimeds Pharmaceuticals US, Inc.
Stock Analysis
Data: 2026-05-07us_universe.csv
- 2025IPOs.csv
- tb_sch.csv
- test_small.csv
- us_AI.csv
- us_cpu.csv
- us_Nuclear.csv
- us_penny_100.csv
- us_penny.csv
- us_Quantum.csv
- us_universe.csv
Last updated: May 07, 2026 at 5:55 AMFresh
show_chart Price & Trend 1.80 • 52W 1.37 - 4.03
Volume
Close
EMA9
MA50
MA150
MA200
Breakout
MA200 Reclaim
MA50 Touch
Pocket Pivot
PB Bounce
EMA9 Cross
auto_graph Pattern Recognition
info
info
Moderate pattern consistency: 50% win rate.
Signal Success Rate
50%
52 total signals
Avg Gain on Winners
+19.5%
26 wins
Avg Loss on Losers
-15.7%
26 losses
Recurring Behaviors
trending_up
Tendency to go on win streaks (longest: 16 signals in a row)
trending_down
Warning: Can experience losing streaks (longest: 9 signals)
rocket_launch
Breakouts outperform pullbacks (50% vs 18% win rate)
show_chart
Tends to make large moves (+/-10%+) after signals
Best Signal Type
PocketPivot
18 signals • 67% win rate
Avg gain: +5.5%
Worst Signal Type
PullbackBounce
2 signals • 0% win rate
Avg loss: -16.4%
All Signal Types (Best ? Worst)
PocketPivot
67%
18 signals
+5.5%
MA200Reclaim
54%
13 signals
+3.6%
Breakout
50%
10 signals
+2.5%
MA50Touch
22%
9 signals
-4.2%
PullbackBounce
0%
2 signals
-16.4%
Trading Insights
lightbulb
Avoid PullbackBounce signals - only 0% successful.
Swing Cycle Analysis
No consistent swing cycles found.
No consistent swing rhythm detected — observed ±8% fluctuations appear irregular or noise-driven.
No reliable swing rhythm detected — fluctuations appear noisy with no actionable cyclic structure.
| Swing | Avg Days | Strength | Pattern? |
|---|---|---|---|
| 8% | 0.0 | 0.00 Weak | — |
? Trough
? Peak
No consistent swing rhythm detected — observed ±8% fluctuations appear irregular or noise-driven.
assessment Key Metrics Universe Updated
Price
$1.80
Score
U
0.536
RS 6M
U
50
RS 3M
U
50
description Recommendation Summary
Underperform
Confidence: 4/10
Performance: B Average
R/C: 24.78:1
UNDERPERFORM (Confidence: 4/10) - Generic Momentum Setup | Neutral/Choppy | Average Momentum | R/R 24.78:1 (Risk 5.0%) | Low-Risk BUY
Trend
Neutral/Choppy
Momentum
Average Momentum
Setup Type
Generic Momentum Setup
grade Absolute Rating
Sell
Standalone Technical Quality
cancel
Trend Strength (Price > MA50, proper stack) (0 points)
cancel
13W Return ? +20% (0 points)
cancel
4W Return ? +8% (0 points)
cancel
Up/Down Volume ? 1.10 (0 points)
cancel
ATR(20) ? 3.5% (0 points)
cancel
Within 5%-25% of 52W High (0 points)
check_circle
Risk/Reward ? 2:1 (R/R 24.78:1) (1 points)
Future Analytics
Coming soon...
security Risk Management
Suggested Stop Loss
$1.71
5.0% riskPotential Upside
+123.9%
R/R: 24.8:1Expected Move (20 d, ATR Proxy)
±$0.97 (53.9%)
Range: $0.83 - $2.77insights What It Means
The stock shows a mix of technical characteristics with moderate relative positioning and a developing composite score. Some developing risks (e.g., Huge 20d expected move ±0.97 (53.9% range)) to monitor. Risk/Reward currently favorable at about 24.8:1, but position sizing should reflect volatility.
Positives
check_circle
Attractive R/C 24.8:1
Negatives / Risks
warning
Huge 20d expected move ±0.97 (53.9% range)
thumb_up Bullish Factors 4
check_circle
Accelerating momentum (3m > 6m RS)
check_circle
Perfect MA stack (MA50 > MA150 > MA200)
check_circle
Strong 1-week gain: +9.8%
check_circle
Risk/Reward: 24.78:1 (Risk 5.0%, Reward 123.9% )
thumb_down Bearish Factors 5
cancel
Weak 6m RS: 50th percentile (underperforming)
cancel
Price below MA50 (short-term weakness)
cancel
Price below MA150 (intermediate weakness)
cancel
Weak accumulation: 0.86x up/down volume
cancel
Far from high: -55.3% off 52-week peak
analytics Technical Indicators
Current Price
$1.80
MA 50
$2.22
-18.8%MA 150
$1.96
-8.3%MA 200
$1.80
0.0%News & Sentiment
Last updated May 07 05:55
Sentiment line (?1..+1) with scaled article volume bars (height relative to sentiment range). Rolling 7d average smooths trend.
Positive day
Negative day
Neutral
Sentiment
7d Avg
Avg 7d: -0.03
Articles 7d: 15
Latest: 0.00 (3)Peak: -0.11 May 4
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
"APUS stock" - Google News
May 06 10:05 AM
0.00
12 Health Care Stocks Moving In Wednesday's Intraday Session Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
"APUS stock" - Google News
May 06 5:06 AM
0.00
12 Health Care Stocks Moving In Wednesday's Pre-Market Session Benzinga
InskoBee: "US Affiliate APUS Rebounds After Trading Suspension Lifted... Risks Resolved, Capital Improvement Expected" - 아시아경제
"APUS stock" - Google News
May 05 11:00 PM
0.00
InskoBee: "US Affiliate APUS Rebounds After Trading Suspension Lifted... Risks Resolved, Capital Improvement Expected" 아시아경제
Apimeds Pharmaceuticals US, Inc. (APUS) Stock: Soars 117% after Settlement Clears Merger Path - parameter.io
"APUS stock" - Google News
May 05 2:42 PM
+0.20
Apimeds Pharmaceuticals US, Inc. (APUS) Stock: Soars 117% after Settlement Clears Merger Path parameter.io
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program - Quantisnow
"APUS stock" - Google News
May 05 12:05 PM
-0.10
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program Quantisnow
Apimeds settles disputes, stock to resume trading today By Investing.com - Investing.com Australia
"APUS stock" - Google News
May 05 11:16 AM
0.00
Apimeds settles disputes, stock to resume trading today By Investing.com Investing.com Australia
Apimeds Pharma shares soar on Inscobee settlement - Investing.com
"APUS stock" - Google News
May 05 11:13 AM
+0.10
Apimeds Pharma shares soar on Inscobee settlement Investing.com
Apimeds Names Sungjoon Chae Co-Chief Executive Officer - TipRanks
"APUS stock" - Google News
May 05 10:12 AM
-0.10
Apimeds Names Sungjoon Chae Co-Chief Executive Officer TipRanks
According to the latest SEC filing, Apimeds Pharmaceuticals US Inc (stock code: APUS) has officially appointed Sungjoon Chae as Co-Chief Executive Officer. - Bitget
"APUS stock" - Google News
May 05 9:58 AM
-0.10
According to the latest SEC filing, Apimeds Pharmaceuticals US Inc (stock code: APUS) has officially appointed Sungjoon Chae as Co-Chief Executive Officer. Bitget
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
APUS stock - BingNews
May 05 5:01 AM
-0.10
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) today announced a comprehensive settlement with Inscobee Inc. and Apimeds Inc. (the "Inscobee Parties"), resolving all outstanding disputes ...
$Apimeds Pharmaceuticals (APUS.US)$ - Moomoo
"APUS stock" - Google News
May 05 12:00 AM
0.00
$Apimeds Pharmaceuticals (APUS.US)$ Moomoo
Apimeds Pharmaceuticals Us Inc APUS
APUS stock - BingNews
May 04 11:00 PM
0.00
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Apimeds Secures Forbearance to Support Listing Remediation - TipRanks
"APUS stock" - Google News
May 04 3:55 AM
-0.10
Apimeds Secures Forbearance to Support Listing Remediation TipRanks
Apimeds (NYSE: APUS) secures $4M, note forbearance and board reset - Stock Titan
"APUS stock" - Google News
May 04 3:15 AM
-0.10
Apimeds (NYSE: APUS) secures $4M, note forbearance and board reset Stock Titan
Stock Scanner
- scienceTestingkeyboard_arrow_down
Stock Scanner v1.0.0
Copyright Ⓒ 2025